FDA Drug Recalls

Recalls / Class II

Class IID-0745-2017

Product

TRI MIX 20/30/2 5ML MDV MCG/MG/MG/1ML INJ, Injection, 20mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial , Prepared by Key Compounding Pharmacy

Affected lot / code info
Lot # t12-07-2016@97, Exp 5/22/2017; t12-12-2016@88, Exp 5/22/2017; t12-20-2016@109, Exp 5/22/2017; t12-20-2016@119, Exp 6/18/2017; t12-23-2016@63, Exp 6/18/2017; t12-30-2016@84, Exp 6/18/2017; t01-09-2017@97, Exp 6/18/2017; t12-22-2016@120, Exp 6/18/2017; t02-07-2017@72, Exp 8/2/2017

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling firm

Firm
Key Pharmacy and Compounding Center
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
530 S 336th St, Federal Way, Washington 98003-6383

Distribution

Quantity
17 vials
Distribution pattern
Distributed nationwide in U.S.A., Australia and Canada.

Timeline

Recall initiated
2017-04-18
FDA classified
2017-05-17
Posted by FDA
2017-05-24
Terminated
2017-08-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0745-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.